Literature DB >> 18510598

White matter lesion severity is associated with reduced cognitive performances in patients with normal CSF Abeta42 levels.

V Stenset1, D Hofoss, L Johnsen, A Skinningsrud, A E Berstad, A Negaard, I Reinvang, L Gjerstad, T Fladby.   

Abstract

OBJECTIVE: To identify possible associations between white matter lesions (WML) and cognition in patients with memory complaints, stratified in groups with normal and low cerebrospinal fluid (CSF) Abeta42 values.
MATERIAL AND METHODS: 215 consecutive patients with subjective memory complaints were retrospectively included. Patients were stratified into two groups with normal (n = 127) or low (n = 88) CSF Abeta42 levels (cut-off is 450 ng/l). Cognitive scores from the Mini-Mental State Examination (MMSE) and the Neurobehavioral Cognitive Status Examination (Cognistat) were used as continuous dependent variables in linear regression. WML load was used as a continuous independent variable and was scored with a visual rating scale. The regression model was corrected for possible confounding factors.
RESULTS: WML were significantly associated with MMSE and all Cognistat subscores except language (repetition and naming) and attention in patients with normal CSF Abeta42 levels. No significant associations were observed in patients with low CSF Abeta42.
CONCLUSIONS: WML were associated with affection of multiple cognitive domains, including delayed recall and executive functions, in patients with normal CSF Abeta42 levels. The lack of such associations for patients with low CSF Abeta42 (i.e. with evidence for amyloid deposition), suggests that amyloid pathology may obscure cognitive effects of WML.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18510598     DOI: 10.1111/j.1600-0404.2008.01045.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

2.  Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis.

Authors:  Lucilla Parnetti; Elena Chipi; Nicola Salvadori; Katia D'Andrea; Paolo Eusebi
Journal:  Alzheimers Res Ther       Date:  2019-01-15       Impact factor: 6.982

3.  Associations of multiple visual rating scales based on structural magnetic resonance imaging with disease severity and cerebrospinal fluid biomarkers in patients with Alzheimer's disease.

Authors:  Mei-Dan Wan; Hui Liu; Xi-Xi Liu; Wei-Wei Zhang; Xue-Wen Xiao; Si-Zhe Zhang; Ya-Ling Jiang; Hui Zhou; Xin-Xin Liao; Ya-Fang Zhou; Bei-Sha Tang; Jun-Ling Wang; Ji-Feng Guo; Bin Jiao; Lu Shen
Journal:  Front Aging Neurosci       Date:  2022-07-29       Impact factor: 5.702

4.  Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns.

Authors:  Lene Pålhaugen; Carole H Sudre; Sandra Tecelao; Arne Nakling; Ina S Almdahl; Lisa F Kalheim; M Jorge Cardoso; Stein H Johnsen; Arvid Rongve; Dag Aarsland; Atle Bjørnerud; Per Selnes; Tormod Fladby
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-21       Impact factor: 6.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.